Muthiah Vaduganathan, MD, MPH
Enriched profileCardiologist and Clinical Trialist, Faculty, Cardiovascular Medicine (Heart and Vascular Center) · Brigham and Women's Hospital
Muthiah Vaduganathan is Cardiologist and Clinical Trialist, Faculty, Cardiovascular Medicine (Heart and Vascular Center) at Brigham and Women's Hospital. OpenAlex indexes 1,168 publications with 90,361 citations (h-index 101); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Muthiah Vaduganathan, MD, MPH, is Cardiologist and Clinical Trialist, Faculty, Cardiovascular Medicine (Heart and Vascular Center) at Brigham and Women's Hospital / Harvard Medical School, Boston, MA. The public record shows 1,168 publications with 90,361 citations (h-index 101), centered on Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Diabetes Treatment and Management. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 34 companies.
- Most recent indexed publication: 2026 · Nephrology, dialysis, transplantation
- Top research focus: Heart Failure Treatment and Management
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 34 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 134 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 540.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
Industry payments
Updated 27 Aug 2026
34 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Lexicon Pharmaceuticals, Inc.Program year20252 payments$49,773openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202517 payments$34,916openpaymentsdata.cms.gov ↗
- Bayer Healthcare Pharmaceuticals Inc.Program year20259 payments$22,384openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.8%Beta blocker21.3%Metoprolol Succinate90%Carvedilol10%Part D<11 patientsStatin19.2%Atorvastatin Calcium72%Rosuvastatin Calcium28%Part D≥47 patientsBlood & clotting
10.3%Factor Xa inhibitor8.3%Eliquis100%Part D≥22 patientsP2Y12 inhibitor2%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
9.8%SGLT2 inhibitor9.8%Jardiance63%Farxiga37%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 27 Aug 2026
4 congress contributions (2020–2025) across ADA per OpenAlex. The most recent:
- 1863-LB: The Confidence Trial—Efficacy/Safety of Combining Finerenone with Empagliflozin in People with Chronic Kidney Disease and Type 2 Diabetes
ADA Scientific Sessions
ADA2025Co-authorLate-breaking - 316-OR: Diabetes Care among Older Adults Enrolled in Medicare Advantage vs. Traditional Medicare Fee-for-Service Plans: The Diabetes Collaborative Registry
ADA Scientific Sessions
ADA2021Co-authorOral - 144-LB: Medicaid Expansion and Utilization of Antihyperglycemic Therapies
ADA Scientific Sessions
ADA2020Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Systolic blood pressure and albuminuria reduction mediate cardiovascular benefits of finerenone in T2 diabetes and CKD.
Nephrology, dialysis, transplantation
Article2026 - A Framework for Risk-Based Implementation of Combination Therapy in CKD: Who, Why, When, and How?
Clinical journal of the American Society of Nephrology
Article2026 - Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.
Hypertension (Dallas, Tex.
Article2026 - Optimal serum potassium concentrations in heart failure: an individual patient data meta-analysis.
European heart journal
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-192,171 citations2020
- 03The Global Burden of Cardiovascular Diseases and Risk2,098 citations2022
- 04The Global Health and Economic Burden of Hospitalizations for Heart Failure2,038 citations2014
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/muthu-vaduganathan-8ba56bab
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Muthiah-Vaduganathan
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - Spotify
open.spotify.com/show/0wLf1OnSnt6rmjImp17z9J
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →open.spotify.com ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/reel/DOI9fU1kakn
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Other
cardionerds.com/382-sglt-inhibitors-the-data-supporting-sglt-inhibition-with-dr-muthiah-vaduganathan
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardionerds.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- MPH
Northwestern University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗ - Board Certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗ - Board Certified
Cardiovascular Disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
Editorial & leadership roles
journal and society appointments- Associate Editor
Journal of the American College of Cardiology (JACC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗ - United States National Ambassador
Heart Failure Association of the European Society of Cardiology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →media.mycme.com ↗
Awards & honors
honors on the public recordSecondary affiliations
appointments beyond the home institution- Co-Director
Center for Cardiometabolic Implementation Science, Brigham and Women's Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗
Media & interviews
press, podcasts and appearances- Host
"Heart Failure in Focus" podcast (Radcliffe Cardiology)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - Guest expert
CardioNerds podcast episode 382 "SGLT Inhibitors: The Data Supporting SGLT Inhibition with Dr. Muthiah Vaduganathan"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardionerds.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital